Concepedia

Shankaran Kothandaraman

SK

Statistics

Publications

9

Citations

223

H-Index

9

Active since

2006

Affiliations

The Ohio State University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Center for Innovation

Shankaran Kothandaraman is an author at The Ohio State University specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2006–2020

9

Publications

9

Pharmacokinetic Properties of Intravitreal I-124-Aflibercept in a Rabbit Model Using PET/CT

John Christoforidis, Michelle M. Williams, Shankaran Kothandaraman et al. · Current Eye Research · 2012 · 60 citations

4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties

Gabor Butora, Gregori J. Morriello, Shankaran Kothandaraman et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 38 citations · Full text

, , +11

Design, synthesis, and structure–activity relationship of novel CCR2 antagonists

Shankaran Kothandaraman, Karla L. Donnely, Gabor Butora et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 25 citations · Full text

, , +3

A High-Affinity Near-Infrared Fluorescent Probe to Target Bombesin Receptors

Ajay Shrivastava, Haiming Ding, Shankaran Kothandaraman et al. · Molecular Imaging and Biology · 2014 · 21 citations · Full text

, , +2

Site Specific Discrete PEGylation of <sup>124</sup>I-Labeled mCC49 Fab′ Fragments Improves Tumor MicroPET/CT Imaging in Mice

Haiming Ding, Michelle M. Carlton, Stephen P. Povoski et al. · Bioconjugate Chemistry · 2013 · 20 citations · Full text

1–5 of 9